The Latest in Alzheimer's & Cognition

Clinical Psychiatry News

AD biomarker not tied to increased interest in physician-assisted death

April 30, 2019

Clinical Psychiatry News

Plasma levels of neurofilament light track neurodegeneration in MCI and Alzheimer’s disease

April 23, 2019

Alzheimer's & Cognition

Clinical Psychiatry News

BACE-1 inhibition worsens cognition in patients with prodromal Alzheimer’s disease

April 10, 2019

Clinical Psychiatry News

Amyloid brain imaging changed clinical management in 60% of MCI and dementia patients

April 2, 2019

Alzheimer's & Cognition

Clinical Psychiatry News

Biogen, Eisai discontinue aducanumab Alzheimer’s trials

March 21, 2019

Alzheimer’s update: George Grossberg

March 13, 2019

Alzheimer's & Cognition

Clinical Psychiatry News

Boosting Alzheimer’s trial participation via Medicare Advantage ‘memory fitness programs’

March 11, 2019

Clinical Psychiatry News

Total plasma tau correlates with dementia onset, Alzheimer’s disease

March 9, 2019

Clinical Psychiatry News

FDA issues warnings to companies selling illegal Alzheimer’s treatments

February 12, 2019

Clinical Psychiatry News

Novel plasma biomarkers may predict preclinical Alzheimer’s disease

February 6, 2019

Clinical Psychiatry News

Phase 3 studies of antiamyloid Alzheimer’s drug crenezumab stopped

January 31, 2019

Clinical Psychiatry News

Frailty may affect the expression of dementia

January 17, 2019

Clinical Psychiatry News

As deep sleep decreases, Alzheimer’s pathology – particularly tau – increases

January 9, 2019

Clinical Psychiatry News

Treating OSA with positive airway pressure decreased amyloid levels in CSF

January 8, 2019

Clinical Psychiatry News

Researchers exploring ways to mitigate aging’s impact on diabetes

January 8, 2019